OR WAIT null SECS
May 02, 2012
Clinical research organizations see reform in clinical-trial process, including the establishment of chief innovation officer at FDA.
October 02, 2011
The authors examine risk management relating to the quality issues of clinical-trial materials and discuss areas that would benefit from additional consideration and harmonization.
February 01, 2011
The author analyzes the results of a survey that polled pharmaceutical executives and managers about both sides of the outsourcing relationship. Read this and other preferred organization articles in this special issue.
October 01, 2010
The FDA has issued a final rule that clarifies what safety information must be reported during clinical trials of investigational drugs and biologics.
August 01, 2010
As emerging markets become increasingly important for the pharmaceutical majors, companies are re-evaluating their outsourcing strategies. This article is part of the 2010 Outsourcing Resources special issue.
July 22, 2010
Pfizer Ends Second Tanezumab Clinical Program; Catalent VP Joins USP Panel; And More.
June 01, 2010
From product development to finished patient kits, Rockwell Automation equipment is used throughout the entire process.
March 01, 2010
The author examines the use and advantages of disposable technologies in the fill–finish of sterile pharmaceutical products and how these technologies can reduce costs and time in producing clinical-trial materials.
June 02, 2009
CROs and CMOs expand to gain a piece of the market for clinical trial materials.
May 01, 2009
The CRO market is experiencing two-tiered growth: firstly from pharmaceutical companies seeking to lower fixed costs by outsourcing clinical research to CROs; and secondly, from biotechnology and specialty pharmaceutical companies that lack the infrastructure to conduct trials.